Home
This Title All WIREs
Introducing:

WIREs Nanomedicine and Nanobiotechnology

  • The first title in the innovative WIREs publication series
  • An authoritative, encyclopedic resource addressing key topics from the perspectives of medicine, biology, physics, chemistry, and engineering
  • High-quality content commissioned from expert contributors and peer-reviewed to a rigorous standard
  • Content is fully citable, qualifying for abstracting, indexing, and ISI ranking

Access to this WIREs title is free to registered institutions.

Register Your Institution Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts

In the Spotlight

Scott McNeil

Scott McNeil
Dr. McNeil is the director of the Nanotechnology Characterization Laboratory for the National Cancer Institute, where he conducts preclinical characterization of nanoparticles intended for cancer therapy and diagnosis. The NCL evaluates nanomaterials using an "assay cascade," which includes physicochemical, in vitro, and in vivo characterization. In laymen's terms, they help cancer researchers get their nanotech-based particles from the lab bench into clinical trials.

Learn More

Twitter: WIREsNanomed Follow us on Twitter